Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:29 AM
Ignite Modification Date:
2025-12-25 @ 4:29 AM
NCT ID:
NCT04961320
Eligibility Criteria:
Inclusion Criteria:
* Aged 18 and over.
* Sufficiently fluent in English.
* Cytologically or pathologically verified diagnosis of renal cell carcinoma (RCC).
* Evidence of metastatic disease.
* Clinician assessed prognosis of greater than or equal to six months.
* Patients who are undergoing immunotherapy treatment (with a checkpoint inhibitor) for advanced kidney cancer who have grade 1 or 2 fatigue based on physician assessment at the time of study entry.
* Willing and independently able to provide consent.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04961320
Study Brief:
Protocol Section:
NCT04961320